SCYNEXIS, Inc.
SCYNEXIS, Inc. (SCYX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
scyx · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for SCYNEXIS, Inc. (SCYX) measures how much investors pay for each dollar of the company's trailing earnings. SCYX's current PE ratio of N/A is calculated by dividing its stock price of $4.45 by its TTM earnings per share of -$3.85.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2012 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
SCYNEXIS, Inc.You SCYX | $28M | N/A | — | -$3.85 |
 CollPlant Biotechnologies Ltd. CLGN | $5M | N/A | — | -$0.94 |
 Cosmos Health Inc. COSM | $14M | N/A | — | -$0.63 |
 Cadrenal Therapeutics, Inc. Common Stock CVKD | $12M | N/A | — | -$6.64 |
 Klotho Neurosciences, Inc. KLTO | $20M | N/A | — | -$0.32 |
 NeuroSense Therapeutics Ltd. NRSN | $19M | N/A | — | -$0.44 |
 NeurAxis, Inc. NRXS | $83M | N/A | — | -$0.86 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-1.38 | — | |
2024-12-31 FY2024 | — | $-3.51 | — | |
2023-12-31 FY2023 | 1.59x | $11.21 | — | |
2022-12-31 FY2022 | — | $-11.79 | — | |
2021-12-31 FY2021 | — | $-9.97 | — | |
2020-12-31 FY2020 | — | $-41.18 | — | |
2019-12-31 FY2019 | — | $-76.62 | — | |
2018-12-31 FY2018 | — | $-22.73 | — | |
2017-12-31 FY2017 | — | $-74.96 | — | |
2016-12-31 FY2016 | — | $-126.04 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for SCYNEXIS, Inc. (SCYX) measures how much investors pay for each dollar of the company's trailing earnings. SCYX's current PE ratio of N/A is calculated by dividing its stock price of $4.45 by its TTM earnings per share of -$3.85.
Frequently asked questions
SCYX pe ratio · 6 questionsSCYX's current PE ratio is N/A as of 2026-06-09, based on a stock price of $4.45 and TTM EPS of -$3.85. Data sourced from Financial Modeling Prep via SCYX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · SCYNEXIS, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09